RADNOR, PA – (NewMediaWire) – December 22, 2024 – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) has informed investors that a securities class action lawsuit has been filed against Kyverna Therapeutics, Inc. (Kyverna) (NASDAQ: KYTX) on behalf of those who purchased Kyverna common stock pursuant to and/or traceable to Kyverna's February 8, 2024 initial public offering (IPO). The lead plaintiff deadline is February 7, 2025.
Contact KESSLER TOPAZ MELTZER & CHECK, LLP:
If you have suffered losses at Kyverna, you can click here or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
You can also contact Attorney Jonathan Nagy, Esq. By calling (484) 270-1453 or via email at info@ktmc.com.
Those accused of misconduct:
The complaint alleges that in the prospectus and registration statements issued in connection with the IPO, Defendants made false and/or misleading statements and/or material omissions regarding the Company's business, operations, and future prospects. Specifically, Defendants made false and/or misleading statements regarding and/or failed to disclose that Kyverna possessed adverse data relating to one of its clinical trials at the time of its IPO.
Lead Plaintiff Process:
Kyverna Investors may, no later than February 7, 2025, seek appointment as lead plaintiff representative for the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may elect to do nothing and remain an absent member of the class. A lead plaintiff is a representative party acting on behalf of all class members in directing the lawsuit. The lead plaintiff is usually the investor or a small group of investors who have the largest financial interest and who are also considered appropriate and typical of the proposed class of investors. The lead plaintiff selects an attorney to represent the lead plaintiff and the class and those attorneys, if approved by the court, are the lead attorneys or the class. Your ability to participate in any recovery is not affected by the decision of whether or not to serve as lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages Kyverna investors who have incurred significant losses to contact the firm directly for further information.
Click here to register for the case or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
About Kessler Topaz Meltzer & Czech LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts across the country and around the world. The company has earned a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by corporations and credit institutions. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Czech LLP, please visit www.ktmc.com.
communication:
Kessler Topaz Meltzer & Czech, LLP
Jonathan Nagy, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, Pennsylvania 19087
info@ktmc.com
It may be considered an attorney's advertisement in some jurisdictions. Past results do not guarantee future results.
View the original version at www.newmediawire.com
Copyright 2024 JCN Newswire. All rights reserved.
